The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells

Toxicology

Volumn 195, Issue 2-3, 2004, Pages 87-95

  Lee, Rami ^a   Kim, Yang Jee ^a   Lee, Young Joon ^a   Chung, Hai Won ^a  

^a Seoul National University   (South Korea)

Author keywords

Antioxidant; Bleomycin; Cytokinesis block micronucleus assay (CBMN); DNA damage; Genistein; HL 60; Lymphocyte; Micronuclei; Single cell gel electrophoresis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; GENISTEIN; ISOFLAVONE DERIVATIVE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROTECTION; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE; MICRONUCLEUS; PRIORITY JOURNAL;

EID: 1642452767     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2003.08.011     Document Type: Article

References (32)

1. Akimoto T., Nonaka T., Ishikawa H., Sakurai H., Saitoh J.I., Takahashi T., Mitsuhashi N. Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Int. J. Radiat. Oncol. Biol. Phys. 50(1):2001;195-201.
2. Albertin J.P., Gurnier-Sullerot A. Iron-BLM deoxyribonucleic acid system: evidence of deoxyribonclei and interaction with the amine group of the β-amino alanine moiety. Biochemistry. 23:1984;47-55.
3. Arora A., Nair M.G., Strasburg G.M. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356:1998;133-141.
4. KB activation in HL60 cells. J. Biol. Chem. 275 (33), 25231-25238.
5. Boos G., Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol. Lett. 116:2000;7-16.
6. Byrnes R.W., Petering D.H. DNA strand breakage in isolated nuclei subjected to bleomycin or hydrogen peroxide. Biochem. Pharmacol. 48:1994;575-582.
7. 2 Mphase of the cell cycle. J. Cell. Biochem. 79:2000;594-600.
8. 2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol. 13:1998;391-396.
9. Beg A.A., Baltimore D. An essential role for NF-kappa B in preventing TNF-alpha-induced apoptosis by NF-kappa B. Science. 274:1996;787-789.
10. Dichiara M.R., Kiely J.M., Gimbrone M.A.J., Lee M.E., Perrella M.A., Topper J.N. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappa B-mediated signals. J. Exp. Med. 192:2000;695-704.
11. Diez-Fernandez C., Andres K., Cascales M. Attenuation effects of heat shock against TGF-B1-induced apoptosis in cultured rat hepatocytes. Free Radic. Biol. Med. 33:2002;835-846.
12. Fenech M. The in vitro micronucleus technique. Mutat. Res. 455:2000;81-95.
13. Guo Q., Rimbach G., Moini M., Weber S., Packer L. ESR and cell culture studies on free radical-scavenging and antioxidant activities of isoflavonoids. Toxicology. 179:2002;171-180.
14. Gyorgy P., Murata K., Ikehata H. Antioxidant isolated from fermented soy beans (tempeh). Nature. 203:1964;870-872.
15. Hillman G.G., Forman F.D., Kucuk O., Yudelev M.et al. Genistein potentiate the radiation effect on prostate carcinoma cells. Clin. Cancer Res. 7:2001;382-390.
16. Hoffmann G.R., Quaranta J.L., Shorter R.A., Littlefield L.G. Modulation of bleomycin induced mitotic recombination in yeast by the aminothiols cysteamine and WR-1065. Mol. Gen. Genet. 249:1995;366-374.
17. Hong J.H., Chiang C.S., Campbell I.L., Sun J.R., Withers H.R., McBride W.H. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;619-626.
18. Jha H.C., von Recklinghausen G., Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem. Pharmacol. 34:1985;1367-1369.
19. Kim H., Peterson T.G., Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor β signaling pathways. Am. J. Clin. Nutr. 68(Suppl.):1998;1418s- 1425s.
20. 2-M. Cancer Res. 53:1993;1328-1331.
21. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer. 11:1994;1675-1682.
22. Povirk, L.K., Finley, Auatin, H.J., 1991. Genotoxicity of bleomycin. Mutat. Res. 257, 127-143.
23. Ruiz-Larrea M.B., Mohan A.R., Paganga G., Miller N.J., Bolwell G.P., Rice-Evans C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 26:1997;63-70.
24. Sierens J., Hartley J.A., Campbell M.J., Leathem A.J.C., Woodside J.V. Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. Mutat. Res. 485:2001;169-176.
25. Sikic B.I. Biochemical and cellular determinants of bleomycin cytotoxicity. Cancer Surv. 5(1):1986;81-91.
26. Solary E., Bertrand R., Pommier Y. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk. Lymphoma. 15(1-2):1994;21-32.
27. Shao Z.M., Wu J., Shen Z.Z., Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58:1998;4851-4857.
28. Stopper H., Muller S.O. Micronuclei as a biological endpoint for genotoxicity: a minireview. Toxicol. In Vitro. 11:1997;661-667.
29. Stubbe J., Kozarich J. Mechanisms of bleomycin-induced DNA degradation. Chem. Rev. 87:1987;1107-1136.
30. WAF1. Clin. Can. Res. 7:2001;1782-1789.
31. Wei H., Wei L., Frenkel K., Bowen R., Barnes S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer. 20:1993;1-12.
32. Win W., Cao Z., Peng X., Trush M.A., Li Y. Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513:2002;113-120.